Editorial: Novel biomarkers in tumor immunity and immunotherapy

Editorial: Novel biomarkers in tumor immunity and immunotherapy

Bibliographic Details
Main Authors:	Takaji Matsutani, Esra Akbay, Eyad Elkord
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Immunology
Subjects:	biomarker ICI bioinformatics tumor immunology transcriptome microbiome
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1405082/full

Similar Items

Editorial: CD4+ T Cells in Cancer Immunotherapies
by: José M. González-Navajas, et al.
Published: (2021-09-01)

Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
by: Murad Alahdal, et al.
Published: (2023-09-01)

Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients
by: Mohammad A. Al-Mterin, et al.
Published: (2022-03-01)

Role of exosomal ncRNAs released by M2 macrophages in tumor progression of gastrointestinal cancers
by: Abdo Meyiah, et al.
Published: (2023-04-01)

Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy
by: Reem Saleh, et al.
Published: (2020-07-01)

Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
by: Belal Chaudhary, et al.
Published: (2016-08-01)

Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy
by: Yurong Qin, et al.
Published: (2024-03-01)

Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients
by: Salman M. Toor, et al.
Published: (2019-12-01)

Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
by: Mohammad A. Al-Mterin, et al.
Published: (2022-08-01)

Editorial: Novel biomarkers for predicting response to cancer immunotherapy
by: Shuchen Huangfu, et al.
Published: (2023-05-01)

Prioritizing exhausted T cell marker genes highlights immune subtypes in pan-cancer
by: Chunlong Zhang, et al.
Published: (2023-04-01)

RNA-Seq Analysis of Colorectal Tumor-Infiltrating Myeloid-Derived Suppressor Cell Subsets Revealed Gene Signatures of Poor Prognosis
by: Reem Saleh, et al.
Published: (2020-11-01)

Editorial: Mediterranean diet and cancer: Experimental and epidemiological perspectives
by: Wamidh H. Talib, et al.
Published: (2022-10-01)

Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
by: Reem Saleh, et al.
Published: (2020-07-01)

Promising use of immune cell‐derived exosomes in the treatment of SARS‐CoV‐2 infections
by: Murad Alahdal, et al.
Published: (2022-08-01)

An immunosuppressive subtype of senescent tumor cells predicted worse immunotherapy response in lung adenocarcinoma
by: Guangyu Fan, et al.
Published: (2023-10-01)

Latent Factor Modeling of scRNA-Seq Data Uncovers Dysregulated Pathways in Autoimmune Disease Patients
by: Giovanni Palla, et al.
Published: (2020-09-01)

Prognostic Neurotransmitter Receptors Genes Are Associated with Immune Response, Inflammation and Cancer Hallmarks in Brain Tumors
by: Yuri Belotti, et al.
Published: (2022-05-01)

Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy
by: David Dora, et al.
Published: (2023-02-01)

Thymus-derived, peripherally-derived and in vitro-induced T regulatory cells
by: Eyad eElkord
Published: (2014-01-01)

An Immune-Related Gene Prognostic Index for Triple-Negative Breast Cancer Integrates Multiple Aspects of Tumor-Immune Microenvironment
by: Xiaowei Wang, et al.
Published: (2021-10-01)

Immune checkpoint inhibitors: recent progress and potential biomarkers
by: Pramod Darvin, et al.
Published: (2018-12-01)

TCR Coexpression Signature Predicts Immunotherapy Resistance in NSCLC
by: Yuntao Wang, et al.
Published: (2022-05-01)

Non-immune cell components in tumor microenvironment influencing lung cancer Immunotherapy
by: Jingtao Zhang, et al.
Published: (2023-10-01)

Predictive biomarkers of colon cancer immunotherapy: Present and future
by: Wanting Hou, et al.
Published: (2022-11-01)

Correlations between Circulating and Tumor-Infiltrating CD4<sup>+</sup> T Cell Subsets with Immune Checkpoints in Colorectal Cancer
by: Mohammad A. Al-Mterin, et al.
Published: (2022-03-01)

TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
by: Anqi Lin, et al.
Published: (2021-09-01)

The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies
by: Jiuhui Xu, et al.
Published: (2023-09-01)

Blockade of PD-1, PD-L1, and TIM-3 Altered Distinct Immune- and Cancer-Related Signaling Pathways in the Transcriptome of Human Breast Cancer Explants
by: Reem Saleh, et al.
Published: (2020-06-01)

Correlations between Circulating and Tumor-Infiltrating CD4<sup>+</sup> Treg Subsets with Immune Checkpoints in Colorectal Cancer Patients with Early and Advanced Stages
by: Mohammad A. Al-Mterin, et al.
Published: (2022-09-01)

DNA Damage Repair in Brain Tumor Immunotherapy
by: Shihong Zhao, et al.
Published: (2022-01-01)

Editorial: New progress in cancer biomarkers and therapy
by: Guohui Sun, et al.
Published: (2024-03-01)

Next generation immuno-oncology tumor profiling using a rapid, non-invasive, computational biophysics biomarker in early-stage breast cancer
by: Daniel Cook, et al.
Published: (2023-04-01)

Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC
by: Ana Oitabén, et al.
Published: (2022-05-01)

Transcriptome of Tumor-Infiltrating T Cells in Colorectal Cancer Patients Uncovered a Unique Gene Signature in CD4<sup>+</sup> T Cells Associated with Poor Disease-Specific Survival
by: Salman M. Toor, et al.
Published: (2021-04-01)

Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma
by: John Wen‐Cheng Chang, et al.
Published: (2023-01-01)

Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections
by: Simone A. Thair, et al.
Published: (2021-01-01)

Integrated Transcriptome and Pathway Analyses Revealed Multiple Activated Pathways in Breast Cancer
by: Radhakrishnan Vishnubalaji, et al.
Published: (2019-09-01)

Targeting regulatory T cells in gastric cancer: Pathogenesis, immunotherapy, and prognosis
by: Bingyu Wang, et al.
Published: (2023-02-01)

The Inflammasomes Adaptor Protein PYCARD Is a Potential Pyroptosis Biomarker Related to Immune Response and Prognosis in Clear Cell Renal Cell Carcinoma
by: Jia-Qi Su, et al.
Published: (2022-10-01)